Publication | Open Access

Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002.

Molecular PharmacologyMammalian TargetSignal TransductionSignaling PathwayMedicinePhosphoinositide 3-Kinase InhibitorsDirect InhibitionCellular PharmacologyCellular BiochemistryPharmacologyCell BiologyCell SignalingInhibitory ActivityProtein PhosphorylationDrug Discovery